Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : 4-Valent HPV Vaccine
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : Merck & Co
Deal Size : Undisclosed
Deal Type : Agreement
Details : Gardasil 4 (4-valent HPV vaccine) is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
December 13, 2022
Lead Product(s) : 4-Valent HPV Vaccine
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : Merck & Co
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Sinovac Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Bio Farma Begins Human Trials of Coronavirus Vaccine in Indonesia
Details : In the clinical trial of the 3 Covid-19 vaccines, Bio Farma will work together with the Phase 3 Clinical Trial Research Team, Faculty of Medicine, UNPAD Bandung for the next six months. If the Phase 3 clinical trial goes well, then the next step is to re...
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
August 08, 2020
Lead Product(s) : COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Sinovac Biotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
